Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cyclophosphamide Versus Ifosfamide for Paediatric and Young Adult Bone and Soft Tissue Sarcoma Patients." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439539/all/Early_pharmacological_interventions_for_acute_traumatic_stress_symptoms:_a_network_meta‐analysis_New. Accessed 18 March 2024.
Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439539/all/Early_pharmacological_interventions_for_acute_traumatic_stress_symptoms:_a_network_meta‐analysis_New. Accessed March 18, 2024.
Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439539/all/Early_pharmacological_interventions_for_acute_traumatic_stress_symptoms:_a_network_meta‐analysis_New
Cyclophosphamide Versus Ifosfamide for Paediatric and Young Adult Bone and Soft Tissue Sarcoma Patients [Internet]. In: Cochrane Abstracts. [cited 2024 March 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439539/all/Early_pharmacological_interventions_for_acute_traumatic_stress_symptoms:_a_network_meta‐analysis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients
ID - 439539
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439539/all/Early_pharmacological_interventions_for_acute_traumatic_stress_symptoms:_a_network_meta‐analysis_New
DB - Evidence Central
DP - Unbound Medicine
ER -